Published • loading... • Updated
Isabella Wanderley Made the Ozempic a Blockbuster in Brazil. Now, She Will Compete Market with Another Pen
Summary by NeoFeed
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
When the Ozempic, a slimming pen based on New Nordisk's semaglutide, became a blockbuster in Brazil in 2022, from the insurrection of statements of influencers on social networks, the company's president in the country was Isabella Wanderley. Now, four years later, she returns to this market, as an entrant and competitor, to try [...] Post Isabella Wanderley made the Ozempic a blockbuster in Brazil. Now, she will compete market with another pen …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
